🔎 Trials Near Me

Home › Heart Failure › Oregon

Heart Failure clinical trials in Oregon

17 studies for Heart Failure are looking for participants at sites in Oregon.

Cities in Oregon

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Oregon Health and Science University, Portland
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Portland
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

  • Research Site, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07690436

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Oregon Health & Science University, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

  • VA Portland Health Care System, Portland, OR, Portland
Recruiting
Ages 60 and older · All sexes · Updated Aug 14, 2026 · NCT05996328

Assessment of CCM in HF With Higher Ejection Fraction

  • Providence Heart & Vascular, Portland
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05064709

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • Providence St. Vincent's - Portland, Portland
  • Oregon Health Science Portland, Portland
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195

CCM OPEN HF Registry

  • Providence St. Vincent Medical Center, Portland
  • Legacy Medical Group Cardiology, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07112924

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Oregon Health & Science University (OHSU), Portland
  • Providence Heart Institute, Portland
Recruiting
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Oregon Health and Science University, Portland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302

Left vs Left Randomized Clinical Trial

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05650658

Cardiogenic Shock Working Group Registry

  • Providence St. Vincent Heart Clinic, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 6, 2025 · NCT04682483

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

  • Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · All sexes · Updated Mar 21, 2025 · NCT06461962

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

  • Providence Heart Institute, Portland
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated May 22, 2024 · NCT06425848

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.